Peginterferon beta (Allozyne)

N/A

Report date: 2022/02/14 09:54:36

Base Information

Drug NamePeginterferon beta (Allozyne)
Drug Alias NameAZ01AZ 01PEGylated interferon-beta (Allozyne)PEG-IFN-beta (Allozyne)Interferon-beta (Allozyne) +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllozyne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllozyne
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A